HUTCHMED (China) Limited

HCM:LNLondon Stock Exchange

Overview

Company Profile

Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceutical company aiming to become a global leader in the discovery, development and commercialisation of targeted therapeutics and immunotherapies in oncology and autoimmune diseases.

Classification

SectorHealthcare
ExchangeLondon Stock Exchange
IndustryPharmaceuticals